Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

598 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term safety and efficacy study of a medical device containing xyloglucan, pea protein reticulated with tannins and xylo-oligosaccharides, in patients with diarrhoea-predominant irritable bowel syndrome.
de Los Rios CC, Falcón BS, Arguelles-Arias F, Pérez E, Teruel C, Geijo F, Rey E. de Los Rios CC, et al. Among authors: rey e. Therap Adv Gastroenterol. 2021 May 30;14:17562848211020570. doi: 10.1177/17562848211020570. eCollection 2021. Therap Adv Gastroenterol. 2021. PMID: 34104216 Free PMC article.
Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive and extra-digestive symptoms.
Serrano-Falcón B, Delgado-Aros S, Mearin F, Ciriza de Los Ríos C, Serra J, Mínguez M, Montoro Huguet M, Perelló A, Santander C, Pérez Aisa Á, Bañón-Rodríguez I, Rey E. Serrano-Falcón B, et al. Among authors: rey e. Therap Adv Gastroenterol. 2019 Aug 5;12:1756284819857358. doi: 10.1177/1756284819857358. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31428193 Free PMC article.
598 results